Distribution of cervical lesions in high-risk HPV (hr-HPV) positive women with ASC-US: a retrospective single-center study in China

被引:32
|
作者
Wang, Zhiling [1 ]
Gu, Ying [1 ]
Wang, Hui [1 ]
Chen, Junyu [2 ]
Zheng, Yawen [1 ]
Cui, Baoxia [1 ]
Yang, Xingsheng [1 ]
机构
[1] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Wenhua West Rd 44, Jinan, Peoples R China
[2] Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Uterine cervical neoplasms; Human papillomavirus; Atypical squamous cells of undetermined significance; Cytology; HUMAN-PAPILLOMAVIRUS INFECTIONS; INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY; FOLLOW-UP; CANCER; CYTOLOGY; TRIAGE;
D O I
10.1186/s12985-020-01455-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BackgroundTo investigate distributions of cervical lesions and factors associated with the severity of the cervical lesions in high-risk HPV (hr-HPV) positive women with atypical squamous cells of undetermined significance (ASC-US) cytology.MethodsClinical information of 250,000 women who underwent HPV and cytological test was collected from January 2012 to January 2019. The association between the severity of the cervical lesions and hr-HPV genotypes, hr-HPV viral load, and ages, were analyzed in hr-HPV-positive/ASC-US women.Results3459 hr-HPV-positive/ASC-US women were enrolled in this study. Overall, 43.51% of women with ASC-US had normal histological results, 34.35% had high-grade squamous intraepithelial lesion (HSIL), and 1.30% had cervical cancer. The rate of HSIL or worse (HSIL+) in women with single HPV16 infection (63.09%) was the highest, followed by HPV33 (57.50%), HPV51 (36.11%), HPV58 (36.11%), HPV52 (28.28%), HPV18 (26.37%), HPV66 (19.35%), HPV39 (18.92%), HPV53 (15.00%), and HPV56 (8.51%). Detection rate of HSIL+ in low, intermediate and high viral-load groups were 15.87% (n=30), 34.91% (n=74) and 40.68% (n=214) (Cochran-Armitage Trend test chi (2)=35.03, p<0.0001). Compared with the 51-60-year-old group (21.65%), the women in<less than or equal to>30 (40.52%), 31-40 (39.67%), and 41-50 (34.22%) year-old groups had significantly higher risk of HSIL+. The women in <= 51-60 (2.68%) and>60 (3.41%) year-old groups were at increased risk for cervical cancer, compared with the <= 30-year-old group (0.61%).ConclusionsASC-US women with HPV 16/18/33/51/52/58 single infection and multiple infections, as well as high HPV viral loads, have high risk of HSIL+.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Clinical outcomes of perimenopausal and postmenopausal women with high risk HPV DNA positive ASC-US interpretation: A retrospective 2 year follow-up study
    Feng, J
    Salimnia, H
    Bandyopadhyay, S
    Al-Abbadi, MA
    Husain, M
    [J]. LABORATORY INVESTIGATION, 2006, 86 : 57A - 57A
  • [22] Clinical outcomes of perimenopausal and postmenopausal women with high risk HPV DNA positive ASC-US interpretation: A retrospective 2 year follow-up study
    Feng, J
    Salimnia, H
    Bandyopadhyay, S
    Al-Abbadi, MA
    Husain, M
    [J]. MODERN PATHOLOGY, 2006, 19 : 57A - 57A
  • [23] Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test
    Ozturk, M.
    Umudum, H.
    Aydin, A.
    Ulubay, M.
    Keskin, U.
    Dede, M.
    Yenen, M. C.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (02) : 232 - 237
  • [24] High-risk Human papillomavirus (HR-HPV) and cervical intraepithelial neoplasia (CIN) in Mexican women of two hospitals
    Hernández-Hernández, DM
    García-Carrancá, A
    Guido-Jiménez, MC
    González-Sánchez, JL
    Cruz-Talonia, F
    Apresa-García, T
    Martínez-Elizondo, OA
    Ornelas-Bernal, L
    Alvarado-Cabrera, I
    Muñoz, S
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2002, 54 (04): : 299 - 306
  • [25] What can we learn from high risk HPV (HR-HPV) positivity among cases upgraded or downgraded to atypical squamous cells of undetermined significance (ASC-US) by the pathologist?
    Kelleher, J. J.
    Rezaei, M. K.
    Yamout, H.
    Poprocky, L.
    Berezowski, K.
    Tabbara, S. O.
    [J]. MODERN PATHOLOGY, 2007, 20 : 73A - 73A
  • [26] Cervical Screening in North Sardinia (Italy): Genotype Distribution and Prevalence of HPV among Women with ASC-US Cytology
    Muresu, Narcisa
    Sotgiu, Giovanni
    Marras, Silvia
    Gentili, Davide
    Sechi, Illari
    Cossu, Andrea
    Dettori, Arianna
    Pietri, Roberto Enrico
    Paoni, Luisa
    Ghi, Maria Eugenia
    Bagella, Maria Paola
    Marrazzu, Adriano
    Cossu, Antonio
    Genovesi, Antonio
    Piana, Andrea
    Saderi, Laura
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (02)
  • [27] Comparison of the Histologic Follow-up Results in Women with ASC-US Cytology and Positive High-Risk HPV testing by HC2, Cervista and Aptima HR HPV Testing Methods: Analysis of 6000 Cases
    Pradhan, Dinesh
    Ashman, Dayne
    Zhao, Chengquan
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 168 - 168
  • [28] What can we learn from high risk HPV (HR-HPV) positivity among cases upgraded or downgraded to atypical squamous cells of undetermined significance (ASC-US) by the pathologist?
    Kelleher, J. J.
    Rezaei, M. K.
    Yamout, H.
    Poprocky, L.
    Berezowski, K.
    Tabbara, S. O.
    [J]. LABORATORY INVESTIGATION, 2007, 87 : 73A - 73A
  • [29] Comparison of the Histologic Follow-up Results in Women with ASC-US Cytology and Positive High-Risk HPV testing by HC2, Cervista and Aptima HR HPV Testing Methods: Analysis of 6000 Cases
    Pradhan, Dinesh
    Ashman, Dayne
    Zhao, Chengquan
    [J]. MODERN PATHOLOGY, 2018, 31 : 168 - 168
  • [30] Molecular characterization of high-risk human papillomavirus (HR-HPV) in women in Lome, Togo
    Kuassi-Kpede, Akouele P.
    Dolou, Essolakina
    Zohoncon, Theodora M.
    Traore, Ina Marie Angele
    Katawa, Gnatoulma
    Ouedraogo, R. Alice
    Traore, Esther Mah
    Bado, Prosper
    Ouedraogo, T. Clarisse
    Djigma, Florencia Wendkuuni
    Karou, Simplice Damintoti
    Simpore, Jacques
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)